Adeline Rosenberg

Senior medical writer at @oxpharmagenesis @_openpharma #PatientEngagement team ♿️ : #hEDS (own opinions; she/her) #Accessibility #DisabledInSTEM

[Kelly Soldavin @KASoldavin]

Join Caroline Halford, @a_e_rosenberg, @SciComm_Jo, and me to interactively investigate the real-world evidence supporting digital features and discover why they are Really Worth the Effort. Register now👉https://t.co/sHSHGzV7IG @ISMPP @tandfmedicine

[Becaris Publishing @_Becaris]

Our co-founder @SciComm_Jo will be joining @a_e_rosenberg, Caroline Halford and @KASoldavin to discuss digital features alongside publications in this @ISMPP U webinar.

[The Health Research Authority @HRA_Latest]

Research sponsors should include a plain language summary of their findings in their final report.

83% of clinical trials who submitted a final report provided a lay summary of results between Sept 2021 and Sept 2022.

Why is providing a summary important? ⬇️
#MakeitPublic

[Kit Yates @Kit_Yates_Maths]

Buried in WhatsApp conversations between then-prime minister Boris Johnson, his scientific advisers and Dominic Cummings, is an exchange which is arguably even more worrying than this headline-grabbing stories.

Johnson's fundamental maths mistake...
🧵1/22

[Eric Topol @EricTopol]

Covid vaccination is associated with significantly reduced incidence of heart attacks and strokes during follow-up. Results of a nationwide @ncats_nih_gov study
https://t.co/YsfQ3Olqj0 @JACCJournals

[Lindsey Brown @LindseyBwork]

Do you have an allergy to cosmetics, washing powder, peanuts, seafood or bee/wasp stings? If you be willing to talk to 1-3 Masters level Immunology students on zoom about your experiences of this please See https://t.co/NlFpTzCBWN for more information and to apply. #FromMeToYou

[Oxford Vaccine Group @OxfordVacGroup]

Our Professor Andrew Pollard talks to @sarahdawood1 on careers in clinical research, future pandemics and vaccine hesitancy.

Read the insightful article below 🔻

@UniofOxford | @OxPaediatrics

[Open Pharma @_OpenPharma]

In an exciting start to 2023, Open Pharma is thrilled to welcome Taylor & Francis as our newest Supporter! A full press release can be found on our blog.

#OpenPharma #Welcome @TandFMedicine #MedicalPublishing

https://t.co/0moZFWH6ZW

[Lindsey Brown @LindseyBwork]

Do you have/have you had one of the conditions below? Would you be willing to talk about your experiences with masters level students who who are studying the immune system? This will take place on zoom. See https://t.co/NlFpTzCBWN for more details and to apply #FromMeToYou

[BendyBrain: Dr Jessica Eccles @BendyBrain]

Glad our @BSMSMedSchool research paper https://t.co/pDkiCwdJOp #hypermobility #adolescence is getting attention @BMJ_Open https://t.co/j61Ltd7i5I

[Prof Nisreen Alwan 🌻 @Dr2NisreenAlwan]

It's not the patient's duty to convince the healthcare professional that they're ill. Once there's reliance on 'convincing' for a health condition to be acknowledged, inequalities follow. Because the ability and capacity to convince are heavily reliant on pre-existing privilege.

[Mollie Katie @molliekatie]

Here's a hot tip: Whenever you see something and think, "Who is this for?! Who could possibly be this lazy?!" Please know that you are looking at an accessibility device for disabled people that the company wouldn't turn a profit on if they didn't market it to abled people too.

[Austin Robert @ar_pnw]

For anyone who thinks #longcovid is new… post-viral illness is 𝐧𝐨𝐭 𝐧𝐞𝐰 and this @TEDTalks by @jenbrea touches on why medicine has failed to find treatments for #mecfs (myalgic encephalomyelitis aka chronic fatigue syndrome) https://t.co/d6NZn4OAkk

[Oxford PharmaGenesis @OxPharmaGenesis]

@LearnedPublish TLDR:
PLS can:
- diversify readership and authorship
- address information inequity
- include typically under-represented stakeholders
- provide an accessible route into the literature

Our co-authors: @_Becaris @futuresciencegp @Plainlang_FSG
#ScholarlyPublishing #DEIA

[Oxford PharmaGenesis @OxPharmaGenesis]

Do you wish that scholarly journal articles were more diverse, equitable, inclusive and accessible?

Peer-reviewed #PlainLanguageSummaries can help!

We outline the evidence base for the value of PLS in a new @LearnedPublish article here.
https://t.co/E3jBjilAmP

[Oxford PharmaGenesis @OxPharmaGenesis]

How should patients be fairly compensated for their time?

Our #HealthyDebate at #ISMPPEurope2023 will explore this and other big #MedComms questions.

Share your thoughts any time by chatting with our team at booth 1 or comment below.
https://t.co/PEcpQpmsfU

[Oxford PharmaGenesis @OxPharmaGenesis]

Here's what you need to know about the role of patients as authors in #MedicalPublications according to the updates to the #GPP2022 guidelines.

What are your thoughts on the changes to GPP? Comment below or drop by booth 1 at #ISMPPEurope2023 for a chat!
https://t.co/PEcpQpmsfU

[Oxford PharmaGenesis @OxPharmaGenesis]

How can patients be included without it being tokenistic?

Our #HealthyDebate at #ISMPPEurope2023 will explore this and other big #MedComms questions.

Share your thoughts any time by chatting with our team at booth 1 or comment below.
https://t.co/PEcpQpmsfU

[Long Covid Advocacy 💙 @LongCovidAdvoc]

7. Profound Educational change is needed for Post Acute Viral Illness
#MECFS #LongCovid

[Long Covid Advocacy 💙 @LongCovidAdvoc]

🧵Still marvelling at the wonder of the @Nature #LongCovid paper.
A few gems:
1. To see fatigue have ACTUAL pathologies listed 😲